Kevin Guest Returns to USANA Health Sciences as CEO
“We thank Jim for his contributions and his leadership over the past 19 years and in his role as CEO over the past 3 years,” said Gilbert Fuller, lead independent director of the Board. “As USANA enters its next phase, the Board believes this transition will position the Company to accelerate strategic priorities that meaningfully contribute to long-term growth opportunities.”
“Kevin has the full support of the Board and the Company’s senior leadership team. He also has good relationships with the Company’s sales force and brings a combination of deep sales, organizational and strategic experience,” continued Mr. Fuller.
“I am truly energized to return to the Company and lead this exceptional organization once again,” Mr. Guest said. “I know firsthand the strength of our sales force and management team, the resilience of our culture, the differentiation of our science-based products, and the meaningful opportunities ahead. I’m grateful to the Board for their confidence, and I look forward to working closely with our team to drive the next chapter of sustainable growth.”
During his eight years as CEO, from 2015 to 2023, Mr. Guest guided USANA through a period of meaningful global expansion, strengthened operational performance, and elevated the Company’s position as a leader in health and wellness. Under his leadership, USANA achieved record results, deepened its presence across key international markets, and reinforced a culture of excellence that continues to define the organization today. His ability to build high‑performing teams, navigate complex industry dynamics, and maintain a clear strategic vision earned the confidence of the Board and the broader USANA community.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as “expect,” “enhance,” “drive,” “anticipate,” “intend,” “improve,” “promote,” “should,” “believe,” “continue,” “plan,” “goal,” “opportunity,” “estimate,” “predict,” “may,” “will,” “could,” and “would,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding Hiya’s growth in 2025 and continued growth in the future; statements about the Company’s long-term growth; and the statements under the sub-heading “Fiscal Year 2025 Outlook.” Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks relating to global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Brand Partners; risk that our Brand Partner compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with our launch of new products or reformulated existing products; risks related to governmental regulation of our products, manufacturing and direct selling business model in
About USANA
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers throughout
View source version on businesswire.com: https://www.businesswire.com/news/home/20260108398726/en/
Investor contact:
Andrew Masuda
Investor Relations
(801) 954-7201
investor.relations@usanainc.com
Media contact:
Sarah Searle
(801) 954-7626
media@usanainc.com
Source: USANA Health Sciences, Inc.